Id |
Subject |
Object |
Predicate |
Lexical cue |
T43 |
0-7 |
Sentence |
denotes |
RESULTS |
T44 |
9-21 |
Sentence |
denotes |
Participants |
T45 |
22-133 |
Sentence |
denotes |
A total of 337 respondents from 267 centers and 37 countries spanning 5 continents completed the online survey. |
T46 |
134-187 |
Sentence |
denotes |
See Figure 1 for the number of responses per country. |
T47 |
188-321 |
Sentence |
denotes |
Most respondents were working in an academic center (n = 286, 84.9%) and the majority of participants were surgeons (n = 302, 89.6%). |
T48 |
322-377 |
Sentence |
denotes |
See Table 1 for the characteristics of the respondents. |
T49 |
378-514 |
Sentence |
denotes |
The median annual hospital and individual surgeon volume of pancreatic resections were 75 (IQR 46–140) and 35 (IQR 20–60), respectively. |
T50 |
515-557 |
Sentence |
denotes |
FIGURE 1 Number of responses per country. |
T51 |
558-597 |
Sentence |
denotes |
TABLE 1 Characteristics of Respondents |
T52 |
599-626 |
Sentence |
denotes |
Impact of COVID-19 Pandemic |
T53 |
627-757 |
Sentence |
denotes |
During the peak of the COVID-19 pandemic, 67.8% (n = 181) of centers prioritized between different types of pancreatic resections. |
T54 |
758-892 |
Sentence |
denotes |
Before pancreatic surgery, most centers screened patients for COVID-19 (n = 233, 87.3%), whereas some centers did not (n = 31, 11.6%). |
T55 |
893-954 |
Sentence |
denotes |
See Table 2 for the preoperative COVID-19 screening strategy. |
T56 |
955-1070 |
Sentence |
denotes |
The majority of centers (n = 166, 62.2%) performed less pancreatic surgery as consequence of the COVID-19 pandemic. |
T57 |
1071-1189 |
Sentence |
denotes |
From these centers, the weekly numbers of pancreatic resections decreased from 3 (IQR 2–5) to 1 (IQR 0–2) (P < 0.001). |
T58 |
1190-1279 |
Sentence |
denotes |
In addition, 30.7% (n = 51) of responding centers performed no pancreatic surgery at all. |
T59 |
1280-1324 |
Sentence |
denotes |
TABLE 2 Preoperative Screening for COVID-19 |
T60 |
1326-1336 |
Sentence |
denotes |
Statements |
T61 |
1337-1452 |
Sentence |
denotes |
Consensus was reached on 13 from the 21 statements (62%) and moderate agreement was achieved on 5 statements (24%). |
T62 |
1453-1502 |
Sentence |
denotes |
The remaining 3 statements had an agreement <60%. |
T63 |
1503-1548 |
Sentence |
denotes |
See Tables 3 to 5 for the statement outcomes. |
T64 |
1549-1586 |
Sentence |
denotes |
TABLE 3 Statement Outcomes—Consensus |
T65 |
1587-1633 |
Sentence |
denotes |
TABLE 4 Statement Outcomes—Moderate Agreement |
T66 |
1634-1676 |
Sentence |
denotes |
TABLE 5 Statement Outcomes——Low Agreement |
T67 |
1678-1698 |
Sentence |
denotes |
Sensitivity Analyses |
T68 |
1699-1830 |
Sentence |
denotes |
The statement outcomes barely changed after excluding the nonacademic centers, without any shifts in the 3 categories of agreement. |
T69 |
1831-2054 |
Sentence |
denotes |
Exclusion of nonsurgeons lead to the movement of statement 5—regarding the prioritization of patients with limited/without comorbidity for surgery to increase the ICU capacity—to the lowest group of agreement (61.1%–59.9%). |
T70 |
2055-2242 |
Sentence |
denotes |
Analyzing the outcomes of Europe (n = 149, 44.2%), Asia (n = 115, 34.1%), and the Americas (ie, North and South America) (n = 71, 21.1%) separately demonstrated some changes in agreement. |
T71 |
2243-2420 |
Sentence |
denotes |
The European respondents did not reach consensus on statement 3 (76.5% agreement) regarding the prioritization of patients based on objective prognostic factors and comorbidity. |
T72 |
2421-2594 |
Sentence |
denotes |
In contrast to the overall outcomes, Asia achieved consensus on statement 4 (81.7% agreement) to prioritize each patient for pancreatic surgery, based on prognostic factors. |
T73 |
2595-2839 |
Sentence |
denotes |
Whereas Europe agreed on the importance of high-volume centers to operate high-risk patients during the COVID-19 pandemic (87.9% agreement), both Asia (75.7% agreement) and the Americas (76.1% agreement) did not reach consensus on statement 16. |
T74 |
2840-2972 |
Sentence |
denotes |
The recommendation for preoperative screening on COVID-19 (statement 19) reached solely consensus (84.5% agreement) in the Americas. |
T75 |
2973-3089 |
Sentence |
denotes |
See Table—Supplemental Digital Content 2–4, for the statement outcomes of Europe, Asia, and the Americas separately. |